Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism "BOX-AF"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Adult patients ≥ 18 years old with a confirmed diagnosis of non-valvular atrial fibrillation
- Patients must in addition present with at least one of following risk factors:
- prior stroke, TIA (transient ischemic attack) or non-CNS (central nervous system) systemic embolism
- left ventricular ejection fraction of < 40%
- symptomatic heart failure, New York Heart Association class 2 or higher
- age ≥75 years
- age ≥65 years in combination with either diabetes, coronary disease or arterial hypertension

Exclusion Criteria

- Patients who do not fulfil the Belgian reimbursement criteria